Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...

Under a mutual agreement with the board of directors, longtime Novo Nordisk CEO Lars Fruergaard Jørgensen—who recently shepherded the company through its GLP-1 growth boom—is heading for the exit.